IMPREDIA SALUD SL
Company details
- Active NIF/CIF: B85681989
-
-
-
-
Address: C/ MAURICIO LEGENDRE NUMERO 15, LOCAL 3 A (MADRID)
-
-
Featured products:
More information on IMPREDIA SALUD SL
-
03/10/2022 | BORME act no.: 436061 | Register: MADRIDReelecciones
-
11/09/2017 | BORME act no.: 365871 | Register: MADRIDReelecciones
-
28/02/2014 | BORME act no.: 95632 | Register: MADRIDCambio de domicilio social
-
21/02/2012 | BORME act no.: 85351 | Register: MADRIDCeses/Dimisiones
-
21/02/2012 | BORME act no.: 85351 | Register: MADRIDNombramientos
-
21/02/2012 | BORME act no.: 85352 | Register: MADRIDNombramientos
-
02/11/2010 | BORME act no.: 957038 | Register: MADRIDDepósito de cuentas anuales (Octubre de 2010)
-
15/02/2010 | BORME act no.: 63164 | Register: MADRIDConstitución
-
15/02/2010 | BORME act no.: 63164 | Register: MADRIDNombramientos
Other information
The CIF assigned to IMPREDIA SALUD SL is B85681989, and its current commercial status is active. The company is engaged in economic activities within the CNAE 8610 - Hospital activities. As for its SIC classification, it is 8099 - Servicios sanitarios y similares.
The company IMPREDIA SALUD SL has a team of Between 1 and 9 employees and reports annual revenues of less than 2 million euros. Registered in the Mercantile Registry of Madrid, it has a total of 4 registered positions. Its most recent announcement in the Borme was published on 03/10/2022, and the last deposit of its annual accounts corresponds to the year 2023.
To find out more contact details of IMPREDIA SALUD SL, such as telephone number, address, or website, you can consult the Company Data module.
If you want to obtain more information about IMPREDIA SALUD SL, you can review one of the available financial reports, the company's Annual Accounts, or check for any default incidents in the RAI delinquency file.
The financial, commercial, and legal information of IMPREDIA SALUD SL comes from official sources and is constantly updated.
Do you want to know more about IMPREDIA SALUD SL??
Find out more about this company by consulting these reports: